Your browser doesn't support javascript.
loading
Chemical and Biological Evidence of the Efficacy of Shengxian Decoction for Treating Human Lung Adenocarcinoma.
Li, Kejuan; You, Fengming; Zhang, Qin; Yuan, Ruijiao; Yuan, Qianghua; Fu, Xi; Ren, Yifeng; Wang, Qian; Li, Xiaohong; Zhang, Zhenya; Shichiri, Mototada; Yu, Yue.
Affiliation
  • Li K; College of Life Science, Sichuan Normal University, Chengdu, China.
  • You F; Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan.
  • Zhang Q; Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Yuan R; College of Life Science, Sichuan Normal University, Chengdu, China.
  • Yuan Q; College of Life Science, Sichuan Normal University, Chengdu, China.
  • Fu X; Oncology Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Ren Y; Oncology Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Wang Q; Oncology Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Li X; Oncology Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Zhang Z; Oncology Department, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Shichiri M; Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Japan.
  • Yu Y; Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ikeda, Japan.
Front Oncol ; 12: 849579, 2022.
Article in En | MEDLINE | ID: mdl-35372052

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Document type: Article Affiliation country: China Country of publication: Switzerland